Fundraising FoxChimera Bioengineering
4 known investors
Find your way into Chimera Bioengineering
Sign up to see every warm intro you have to Chimera Bioengineering
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chimera Bioengineering team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.
Investors · 4
ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto
How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us
Western Technology Investmentlisted by Western Technology InvestmentPortola Valley
How we know: westerntech.com · Not right? Tell us
PureTech HealthreportedBoston
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Chimera Bioengineering do?
- Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.
- Who are Chimera Bioengineering's investors?
- Chimera Bioengineering's investors include Sand Hill Angels, ShangBay Capital LLC, Western Technology Investment, PureTech Health.